Arcutis Biotherapeutics, Inc. (ARQT)
29.04
+0.96
(+3.42%)
USD |
NASDAQ |
Dec 31, 16:00
28.80
-0.24
(-0.83%)
After-Hours: 20:00
Arcutis Biotherapeutics Free Cash Flow: -48.24M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CorMedix, Inc. | 74.42M |
| ADMA Biologics, Inc. | 40.61M |
| ANI Pharmaceuticals, Inc. | 136.04M |
| Editas Medicine, Inc. | -180.70M |
| Amicus Therapeutics, Inc. | 9.691M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.754M |
| Cash from Investing (Quarterly) | -25.25M |
| Cash from Financing (Quarterly) | 1.476M |
| Free Cash Flow Per Share (Quarterly) | -0.0132 |
| Free Cash Flow to Equity (Quarterly) | -5.365M |
| Free Cash Flow to Firm (Quarterly) | 1.284M |
| Free Cash Flow Yield | -1.30% |